Is intermittent fasting safe and effective for people with type 2 diabetes?

Intermittent fasting has been studied for weight loss and blood sugar control, but safety depends on medication use, hypoglycaemia risk, and individual health factors. In this episode, we explain how fasting is evaluated in people with type 2 diabetes in Europe.

In this episode, we cover:

• What intermittent fasting is (time-restricted eating or alternate-day fasting)

• How fasting affects insulin sensitivity and glucose levels

• Evidence on HbA1c, weight, and metabolic markers

• Risks of hypoglycaemia in patients on insulin or sulfonylureas

• Adjusting medication during fasting periods

• Who should avoid fasting (pregnancy, eating disorders, advanced kidney disease)

• Warning signs requiring medical review

• Situations where treatment adjustments may be declined without monitoring

Doctors assess HbA1c, medication regimen, kidney function, cardiovascular history, BMI, and hypoglycaemia risk before advising on fasting. Blood glucose monitoring is essential. Some patients require in-person review or medication changes prior to attempting fasting.

This episode reflects how lifestyle interventions and diabetes treatment are reviewed within structured medical assessment in European telemedicine at Mobi Doctor.

Read the full medical guide here:

https://www.mobidoctor.eu/blog/intermittent-fasting-is-safe-and-effective-for-people-with-type-2-diabetes